Vivani Medical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vivani Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Vivani Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.04M, a 10.9% increase year-over-year.
  • Vivani Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$23.5M, a 12.8% increase year-over-year.
  • Vivani Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$25.7M, a 84.7% decline from 2022.
  • Vivani Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.9M, a 8.74% decline from 2021.
  • Vivani Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.8M, a 14.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.5M -$6.04M +$741K +10.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$24.2M -$5.36M +$1.17M +17.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$25.4M -$6.04M +$279K +4.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$25.7M -$6.03M +$1.26M +17.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$26.9M -$6.78M -$8.21M -577% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$18.7M -$6.53M -$2.42M -59% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$16.3M -$6.32M -$2.39M -61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$13.9M -$7.28M -$6M -468% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$7.89M $1.42M +$4.91M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$12.8M -$4.1M -$1.43M -53.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$11.4M -$3.92M -$936K -31.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$10.4M -$1.28M +$8K +0.62% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-29
Q3 2021 -$10.4M -$3.49M -$1.89M -118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.56M -$2.68M +$425K +13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$8.98M -$2.99M +$5.9M +66.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$14.9M -$1.29M +$6.58M +83.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$21.5M -$1.6M +$5.98M +78.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-29
Q2 2020 -$27.4M -$3.1M +$5.34M +63.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-29
Q1 2020 -$32.8M -$8.89M +$814K +8.39% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-29
Q4 2019 -$33.6M -$7.87M +$990K +11.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$34.6M -$7.58M +$938K +11% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 -$35.5M -$8.44M -$479K -6.02% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 -$35M -$9.7M +$53K +0.54% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 -$35.1M -$8.86M -$1.45M -19.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$33.6M -$8.52M -$1.81M -26.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-19
Q2 2018 -$31.8M -$7.96M -$1.12M -16.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-19
Q1 2018 -$30.7M -$9.75M -$2.21M -29.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-19
Q4 2017 -$28.5M -$7.41M +$2.96M +28.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-19
Q3 2017 -$31.5M -$6.72M +$1.77M +20.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-19
Q2 2017 -$33.3M -$6.84M +$1.66M +19.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-19
Q1 2017 -$34.9M -$7.55M -$1.73M -29.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-19
Q4 2016 -$33.2M -$10.4M -$4.9M -89.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$28.3M -$8.49M -$3.82M -81.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 -$24.5M -$8.5M -$3.58M -72.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 -$20.9M -$5.82M -$860K -17.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 -$20M -$5.47M +$8.1M +59.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$28.1M -$4.67M +$2.98M +39% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$31.1M -$4.92M +$2.62M +34.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$33.7M -$4.96M +$1.48M +23% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$35.2M -$13.6M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$7.64M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$7.54M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$6.44M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.